American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on May 16, 2025

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of…

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of…

PALO ALTO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …

XRP holders flock to EarnMining cloud mining platform to obtain high fixed potential income every day

XRP holders flock to EarnMining cloud mining platform to obtain high fixed potential income every day

Los Angeles, California, May 16, 2025 (GLOBE NEWSWIRE) -- The world of crypto is evolving fast—and so are the opportunities to earn from it. XRP holders, in particular, are now discovering a powerful, low-effort method to generate passive income: cloud …

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …

Spectral Medical to Present at the 3rd Annual  H.C. Wainwright BioConnect Investor Conference

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …

Richtech Robotics Expands ADAM Robot Capabilities with AI Powered Artisanal Espresso System

Richtech Robotics Expands ADAM Robot Capabilities with AI Powered Artisanal Espresso System

New system utilizes advancements in physical AI to provide customers efficient and precise artisanal coffee products Las Vegas, NV, May 16, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based …

Global Technologies, Ltd. Files Third Quarter 10-Q with SEC Highlighting Substantial Revenue Growth and Strategic Expansion

Global Technologies, Ltd. Files Third Quarter 10-Q with SEC Highlighting Substantial Revenue Growth and Strategic Expansion

GREENSBORO, NC, May 16, 2025 (GLOBE NEWSWIRE) -- Global Technologies, Ltd. (OTC PINK: GTLL) (“Global” or the “Company”), a publicly traded, multi-operational company driving innovation and sustainable growth across the technology and service sectors, today …

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …

AgEagle Aerial Systems Reports First Quarter Fiscal Year 2025 Financial Results

AgEagle Aerial Systems Reports First Quarter Fiscal Year 2025 Financial Results

Improved financial performance highlighted by strong gross margin improvement and significant reduction in operating expenses  WICHITA, Kan., May 16, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of best-in-class …

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service